Single-Use Bioprocessing Market Overview
The Single-Use Bioprocessing Market is expanding as biopharmaceutical manufacturers increasingly adopt flexible and cost-effective production technologies that can reduce contamination risks, cleaning requirements, and manufacturing downtime. Rising demand for biologics, cell and gene therapies, personalized medicine, and scalable manufacturing is accelerating the transition from traditional stainless-steel systems toward disposable bioprocessing solutions.
According to the WiseGuyReports report published in August 2026, the global Single-Use Bioprocessing Market was valued at USD 8.3 Billion in 2024 and USD 9.2 Billion in 2025 and is projected to reach USD 25 Billion by 2035, registering a CAGR of 10.6% during 2026–2035. North America is anticipated to lead the market, supported by strong biopharmaceutical research and development activity, while Asia-Pacific is expected to register the highest growth rate. Filtration is the largest application segment, with a market value of USD 1.233 Billion in 2024 projected to reach USD 3.879 Billion by 2035. Pharmaceutical Companies represent a major end-user group, while Plastic holds a prominent position among materials used in single-use systems.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/reports/single-use-bioprocessing-market
Key players driving innovation and competitiveness in the Single-Use Bioprocessing Market include:
CITEC
ABEC
Repligen Corporation
Danaher Corporation
Fujifilm Diosynth Biotechnologies
Lonza Group
Kornelis
Eppendorf AG
Western Biotech
Cellares
Pall Corporation
Thermo Fisher Scientific
Meissner Filtration Products
GE Healthcare
Merck KGaA
Sartorius AG
The market is being shaped by increasing demand for biopharmaceuticals, the need for flexible and scalable manufacturing, regulatory support for single-use systems, technological advances in materials and connection technologies, and growing emphasis on cost-effective production. Improved sensors and real-time monitoring capabilities are enhancing process control, while single-use systems can help manufacturers reduce contamination risks and eliminate many cleaning and sterilization requirements associated with traditional equipment. Sustainability and waste-management considerations are also encouraging manufacturers to develop more environmentally responsible materials and systems.
The Single-Use Bioprocessing Market can be segmented by Application into Cell Culture, Virus Production, Protein Purification, Filtration, and Buffer Preparation. By Product Type, it includes Bioreactors, Filtration Devices, Bags and Containers, Tubing and Connectors, and Service and Support. By End User, the market covers Pharmaceutical Companies, Biotechnology Companies, CROs, and Academic Research Institutions. By Material, it comprises Plastic, Elastomers, Silicone, and Polypropylene. Regionally, the market covers North America, Europe, South America, Asia Pacific, and the Middle East and Africa.
The rapidly growing biopharmaceutical industry is creating opportunities for manufacturers of disposable bioreactors, filtration systems, bags, connectors, sensors, and other single-use components. Emerging biotechnology companies can use these systems to establish scalable production without the heavy infrastructure investment associated with conventional facilities. Growing adoption of personalized medicine and cell and gene therapies is also creating demand for flexible manufacturing platforms, while Asia-Pacific and Latin America offer opportunities as biopharmaceutical infrastructure and production capacity expand.
Recent Developments and Market Trends:
Single-use technologies are gaining momentum as biopharmaceutical manufacturers seek to reduce contamination risks, shorten production timelines, and improve flexibility compared with traditional stainless-steel systems.
Filtration is a major application area, with its market value projected to increase from USD 1.233 Billion in 2024 to USD 3.879 Billion by 2035 as demand for efficient separation and purification of biologics grows.
Advanced materials, improved connection systems, and integrated sensors are enhancing the performance, safety, and monitoring capabilities of single-use bioprocessing equipment.
In March 2025, Lonza announced a strategic partnership with Meissner Filtration Products to co-develop next-generation single-use filtration solutions for scalable bioprocessing and closed-system manufacturing.
In June 2025, Cellares launched its CellsPod automated and modular cell-therapy manufacturing platform, integrating with single-use bioprocess components to support scalable closed manufacturing.
Reasons to Buy the Report:
Provides comprehensive insights into the Single-Use Bioprocessing Market dynamics, trends, opportunities, competitive landscape, and growth potential.
Helps identify opportunities across cell culture, virus production, protein purification, filtration, and buffer preparation applications.
Offers detailed segmentation analysis across application, product type, end user, material, and regional markets.
Includes competitive intelligence covering leading bioprocessing, filtration, biopharmaceutical manufacturing, and life-sciences technology companies.
Supports informed decisions using market forecasts, biopharmaceutical demand trends, manufacturing flexibility, regulatory developments, technological advancements, and regional growth opportunities.
Future Outlook:
The future of the Single-Use Bioprocessing Market will be shaped by the continued expansion of biologics, increasing adoption of cell and gene therapies, demand for flexible manufacturing, and advances in disposable bioprocessing technologies. Filtration should remain a leading application, supported by growing requirements for efficient purification and separation processes. Bioreactors, filtration devices, bags and containers, and tubing and connectors should continue to benefit from the transition toward flexible production platforms. Pharmaceutical Companies are expected to remain a major end-user group, while Biotechnology Companies and CROs should increasingly adopt single-use systems to support scalable development and manufacturing. Plastic should retain a prominent role among materials, although demand for improved, sustainable, and biocompatible materials is expected to increase. North America should maintain its leading position, while Asia-Pacific is expected to record the highest growth rate as biomanufacturing investment and healthcare infrastructure expand. WiseGuyReports projects the global market to reach USD 25 Billion by 2035 at a CAGR of 10.6% during 2026–2035.
➤➤Explore Our Latest Related Reports:
